Slow transit constipation is notoriously difficult to treat. We tested
whether polyethylene glycole 4000 (PEG) improves slow transit constip
ation. Eight female outpatients with symptoms of constipation and a co
lonic marker transit of more than 60 h were included (age 46+/-4y, dur
ation of complaints 17+/-3y) in a randomised controlled cross-over stu
dy. During a 6-week placebo and 6-week PEG-phase (60g PEG/d) the follo
wing parameters were measured: 1. subjective well-being with respect t
o defeacation on a visual analogue scale (-8 cm very bad, +8 cm very g
ood), 2. in the first 5 weeks of each phase, average dose of sodium pi
cosulfate (prescribed as only allowed laxans, dose adjusted and protoc
olled on a diary by patient) 3. stool frequency, 4. colonic transit of
radiopague polythene pellets in the last week of each phase (the use
of laxative was strictly prohibited in this last week). Both subjectiv
e and objective parameters of colonic function improved significantly.
Visual analog scale ratings improved from -4.65, [-8; 0.5] to 4.65, [
-8; 7.5]cm (median, range) (p=0.028), the self-administered dose of so
dium picosulfate decreased from 4, [0; 37] to 0, [0; 11] drops per day
(p=0.028), stool frequency increased from 3.1, [1; 30] to 11, [2; 33]
defaecations per week (p=0.017), and total colonic transit decreased
from 91, [67; 116] to 43 h, [17; 76]h (p=0.017). In conclusion, PEG im
proves colonic function in patients with slow transit constipation sub
jectively and objectively. PEG should be considered as an additional o
ption in patients refractory to established forms of treatment.